文献速递新生儿儿童内分泌与遗传代谢

分级静脉葡萄糖方案降低新生儿低血糖血糖波动、NICU住院时间与费用

A Graded Approach to Intravenous Dextrose for Neonatal Hypoglycemia Decreases Blood Glucose Variability, Time in the Neonatal Intensive Care Unit, and Cost of Stay.
PubMed 文献 · J Pediatr · 2020-12-15

回顾性队列研究纳入277名≥35周新生儿,比较分级静脉葡萄糖方案实施前后血糖变化、NICU住院时间和费用。

要点

  • 分级静脉葡萄糖方案与更低的血糖波动相关。
  • 分级方案与NICU住院时间缩短及费用降低相关。
  • 达到正常血糖时间在方案前后无显著差异。

核心结论

  • 分级静脉葡萄糖方案与新生儿低血糖患儿血糖波动性降低、NICU住院时间缩短及费用降低相关。

研究设计与样本

  • 回顾性队列研究,纳入城市学术分娩医院277名≥35周新生儿,比较方案改变前后两个时期的结局。
  • 时期1所有需静脉葡萄糖的低血糖患儿给予推注后以60 mL/kg/day起始。
  • 时期2根据低血糖程度给予30或60 mL/kg/day静脉葡萄糖。
  • 采用校正中位数回归比较两时期血糖结局、住院时间和费用的差异。

主要发现

  • 时期2静脉葡萄糖起始后血糖上升中位数(IQR)为19(10, 31)mg/dL,显著低于时期1的24(14, 37)mg/dL,校正β=-6.0 mg/dL,95%CI -11.2, -0.8。
  • 达到正常血糖时间在两时期无显著差异。
  • NICU住院天数中位数(IQR)从4.5(2.1, 11.0)天降至3.0(1.5, 6.5)天,校正β=-1.9,95%CI -3.0, -0.7。

关键数值与推荐

  • 时期1方案:所有需静脉葡萄糖的低血糖患儿给予推注后以60 mL/kg/day起始。
  • 时期2方案:根据低血糖程度给予30或60 mL/kg/day静脉葡萄糖。

临床怎么用

  • 对≥35周新生儿低血糖,可考虑根据低血糖程度分级起始静脉葡萄糖输注速度(30或60 mL/kg/day),而非统一60 mL/kg/day。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine associations between a graded approach to intravenous (IV) dextrose treatment for neonatal hypoglycemia and changes in blood glucose (BG), length of stay (LOS), and cost of care. STUDY DESIGN: Retrospective cohort study of 277 infants born at ≥35 weeks of gestation in an urban academic delivery hospital, comparing the change in BG after IV dextrose initiation, neonatal intensive care unit (NICU) LOS, and cost of care in epochs before and after a hospital protocol change. During epoch 1, all infants who needed IV dextrose for hypoglycemia were given a bolus and started on IV dextrose at 60 mL/kg/day. During epoch 2, infants received IV dextrose at 30 or 60 mL/kg/day based on the degree of hypoglycemia. Differences in BG outcomes, LOS, and cost of hospital care between epochs were compared using adjusted median regression. RESULTS: In epoch 2, the median (IQR) rise in BG after initiating IV dextrose (19 [10, 31] mg/dL) was significantly lower than in epoch 1 (24 [14,37] mg/dL; adjusted β = -6.0 mg/dL, 95% CI -11.2, -0.8). Time to normoglycemia did not differ significantly between epochs. NICU days decreased from a median (IQR) of 4.5 (2.1, 11.0) to 3.0 (1.5, 6.5) (adjusted β = -1.9, 95% CI -3.0, -0.7). Costs associated with NICU hospitalization decreased from a median (IQR) $14 030 ($5847, $30 753) to $8470 ($5650, $19 019) (adjusted β = -$4417, 95% CI -$571, -$8263) after guideline implementation. CONCLUSIONS: A graded approach to IV dextrose was associated with decreased BG lability and length and cost of NICU stay for infants with neonatal hypoglycemia.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Sen S, Cherkerzian S, Turner D, et al. A Graded Approach to Intravenous Dextrose for Neonatal Hypoglycemia Decreases Blood Glucose Variability, Time in the Neonatal Intensive Care Unit, and Cost of Stay. J Pediatr. 2020. PMID: 33338495. doi:10.1016/j.jpeds.2020.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。